Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Mini Oral session: Breast cancer, early stage

137MO - Effect of peri-tumoral infiltration of local anaesthetic prior to surgery on survival in early breast cancer

Date

12 Sep 2022

Session

Mini Oral session: Breast cancer, early stage

Topics

Patient Education and Advocacy;  Clinical Research;  Primary Prevention;  Surgical Oncology

Tumour Site

Breast Cancer

Presenters

Rajendra Badwe

Citation

Annals of Oncology (2022) 33 (suppl_7): S55-S84. 10.1016/annonc/annonc1038

Authors

R.A. Badwe1, V. Parmar2, N.S. Nair2, R. Hawaldar3, S. Joshi4, S. Pawar5, G. Kadayaprath6, B. Borthakur7, S. Rao8, S. Pandya9, S. B10, P. Chitale11, R. Neve12, C. Harris13, A. Srivastava14, S. Siddique3, V. Vanmali2, A. Dewade15, V. Gaikwad15, S. Gupta16

Author affiliations

  • 1 Surgical Oncology, Tata Memorial Centre, 400 012 - Mumbai/IN
  • 2 Surgical Oncology Department, Tata Memorial Hospital - Tata Memorial Centre, 400012 - mumbai/IN
  • 3 Clinical Research Secretariat, Tata Memorial Hospital - Tata Memorial Centre, 400012 - Mumbai/IN
  • 4 Surgical Oncology Department, Tata Memorial Hospital - Parel, 400004 - Mumbai/IN
  • 5 Surgical Oncology Department, Kolhapur Cancer Centre, 416234 - Kolhapur/IN
  • 6 Surgical Oncology Department, Max Hospital Delhi, 110091 - Delhi/IN
  • 7 Surgical Oncology Department, B. Borooah Cancer Institute, Guwahati, 781016 - Guwahati/IN
  • 8 Surgical Oncology Department, American Cancer Hospital and Research Centre, 500034 - Hyderabad/IN
  • 9 Surgical Oncology Department, GCRI - The Gujarat Cancer and Research Institute, 380016 - Ahmedabad/IN
  • 10 Surgical Oncology Department, Malabar Cancer Centre, 670103 - Thalassery/IN
  • 11 Surgical Oncology Department, Shree Siddhivinayak Ganapati Cancer Hospital, 416410 - Miraj/IN
  • 12 Surgical Oncology Department, Sterling Multi-Speciality Hospital, 411044 - Pune/IN
  • 13 Surgical Oncology Department, NEIGRIHMS - North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, 793018 - Shillong/IN
  • 14 Surgical Oncology Department, AIIMS - All India Institute of Medical Sciences, 110029 - New Delhi/IN
  • 15 Clinical Research Secretariat, Tata Memorial Hospital - Parel, 400004 - Mumbai/IN
  • 16 Medical Oncology Department, Tata Memorial Hospital - Tata Memorial Centre, 400012 - Mumbai/IN
More

Resources

Login to access the resources on OncologyPRO.

Abstract 137MO

Background

Preventing initiation of micro metastases from early breast cancer by peri-operative intervention has not been explored adequately. Local anaesthesia blocks voltage gated sodium channels which prevents activation of pro-metastatic pathways. A Cochrane review of using local anaesthesia before surgery for breast cancer concluded inadequate data on its efficacy. We conducted a multi-centre randomized trial to test the impact of peri-tumoral infiltration of local anaesthesia before surgery on survival in women with early breast cancer.

Methods

Women with early breast cancer were randomized, to receive peri-tumoral injection of 0.5% lidocaine, 5-10 minutes before surgery (LA arm) or surgery without lidocaine(No-LA arm). Randomisation was stratified by menopausal status and tumour size. Women on neo-adjuvant chemotherapy were not included in the study. Participants underwent breast conservation or modified radical mastectomy and received standard post-operative adjuvant radiotherapy and systemic therapy. The primary endpoint was disease-free survival(DFS) and the secondary endpoint was overall survival(OS).

Results

The study included 1600 patients randomized to LA(N=796) and No-LA(N=804) arms, of whom 1583 were included in the analysis. At 72 months there were 255 DFS events (109 LA arm, 146 No-LA arm). At 6-year DFS were 86.1% and 81.7% in LA and No-LA arms, respectively (HR 0.74, 95% CI 0.58-0.95, p=0.017) and OS were 89.9% and 86.2%, respectively (HR 0.71, 95% CI 0.53-0.94, p=0.019). The impact of LA was similar in subgroups defined by menopausal status, tumour size, lymph node metastases, hormone receptor and HER2neu status. In the LA and no-LA arm, the loco-regional DFS were 94.8% and 92.3%, respectively (HR=0.67, 95%CI 0.45-0.99, p=0.04) and distant DFS were 89.2% and 85.1%, respectively (HR=0.70, 95%CI 0.53 – 0.94, p=0.013). There were no adverse events due to lidocaine injection.

Conclusions

Peri-tumoral injection of lidocaine before surgery is a simple implementable intervention that can reduce 1 of 4 recurrences and 3 of 10 deaths in women with early breast cancer. Altering events at the time of surgery can prevent metastases in women with early breast cancer(CTRI/2014/11/005228).

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Tata Memorial Centre, Mumbai, India.

Funding

Department of Atomic Energy, Government of India.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.